688331 荣昌生物
2025/06 - 中期
人民币(K¥)
与去年末期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)

非流动资产
长期股权投资8,738-1.28%8,8512,7051,5000
投资性房地产0--0000
固定资产2,367,746-3.64%2,457,1802,031,3061,387,275967,005
在建工程406,42043.49%283,231795,7181,014,928610,682
无形资产153,9027.53%143,131143,78155,86152,399
商誉0--0000
其他非流动资产215,391-31.91%316,328325,798349,487229,170
3,152,198-1.76%3,208,7223,299,3092,809,0531,859,257

流动资产
货币资金1,273,91567.07%762,492743,3932,187,3261,835,498
应收账款355,326-7.32%383,389297,678202,0302,312
存货641,247-2.75%659,369741,560522,673280,314
其他流动资产427,672-11.74%484,547446,302300,108181,828
2,698,16017.83%2,289,7962,228,9323,212,1372,299,952

流动负债
短期借款1,320,55321.84%1,083,854284,27700
应付票据0--013,994112,820122,738
应付帐款209,20228.94%162,250125,337108,87336,521
其他流动负债1,018,1409.22%932,193704,515655,260452,702
2,547,89516.97%2,178,2971,128,123876,953611,961
流动资产净值150,26534.77%111,5001,100,8092,335,1841,687,991
资产总额减流动负债3,302,463-0.53%3,320,2224,400,1185,144,2373,547,248

非流动负债
长期借款816,730-31.70%1,195,878840,58800
应付债券0--0000
其他非流动负债128,242-7.17%138,143122,262163,937100,827
944,973-29.16%1,334,021962,850163,937100,827

总权益
    实收股本563,6083.54%544,332544,263544,263489,837
    储备项目1,793,88224.41%1,441,8692,893,0054,436,0372,956,585
股东权益2,357,49118.69%1,986,2013,437,2684,980,3003,446,421
非控股权益0--0000